Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;44(1):228-36.
doi: 10.1007/s12020-012-9856-z. Epub 2012 Dec 20.

Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass

Affiliations

Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass

Andreas Muth et al. Endocrine. 2013 Aug.

Abstract

The aim of this study was to assess patient-reported impacts and health-related quality of life (HRQL) of a 2-year follow-up programme in a large cohort of patients with stationary, non-functioning, adrenal incidentalomas (AIs) in western Sweden. 145 patients (mean age 68 years, 62 % females) with AI from a prospective study in western Sweden were studied. All had completed a 2-year follow-up programme by November 2007, without evidence of adrenal malignancy or hormone over-production. To evaluate patient-reported impacts and HRQL, an eight-item adrenal incidentaloma impact questionnaire was used retrospectively, together with the hospital anxiety and depression scale, and the short form-36. There were 111 patients (mean age 67 years, 63 % females) who responded to the questionnaire (response rate 77 %). 77 % reported that the AI diagnosis had caused them to be worried; however, fewer than 20 % had thought about the lesion often during the follow-up programme, and only 3 % had felt that it had a large impact on their current daily life. Only 4 % stated that the follow-up programme had been a negative experience, nevertheless 10 % reported a negative impact on their HRQL during the follow-up programme. Only 2 % stated that release from follow-up caused worry to any degree. In total, 29 % had possible anxiety, and 30 % had possible depression, probably reflecting significant co-morbidity. Possible anxiety correlated with a more negative experience of the follow-up programme. In conclusion, the 2-year follow-up programme for patients with AI was well tolerated. Nonetheless, a small number remained worried throughout follow-up, suggesting the need for tailored counselling in individual patients to ameliorate negative impacts of follow-up.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The adrenal incidentaloma impact questionnaire, distribution of responses for each item. Items grouped according to the factor analysis. a Preoccupation with the adrenal incidentaloma. b Evaluation of the follow-up programme
Fig. 2
Fig. 2
The short form-36—results for respondents versus age and gender-matched norms legend: means for individual domains for the respondents (solid line) and an age and sex-matched reference sample drawn from the Swedish norm database (hatched line). Differences were statistically significant in all domains (p = 0.00004–0.009), except BP (p = 0.085). PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health

References

    1. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991;110(6):1014–1021. - PubMed
    1. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 2000;85(2):637–644. doi: 10.1210/jc.85.2.637. - DOI - PubMed
    1. Bulow B, Ahren B. Adrenal incidentaloma—experience of a standardized diagnostic programme in the Swedish prospective study. J. Intern. Med. 2002;252(3):239–246. doi: 10.1046/j.1365-2796.2002.01028.x. - DOI - PubMed
    1. Bulow B, Jansson S, Juhlin C, Steen L, Thoren M, Wahrenberg H, Valdemarsson S, Wangberg B, Ahren B. Adrenal incidentaloma—follow-up results from a Swedish prospective study. Eur. J. Endocrinol. 2006;154(3):419–423. doi: 10.1530/eje.1.02110. - DOI - PubMed
    1. Kasperlik-Zaluska AA, Otto M, Cichocki A, Roslonowska E, Slowinska-Srzednicka J, Jeske W, Papierska L, Zgliczynski W. Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm. Metab. Res. 2008;40(5):338–341. doi: 10.1055/s-2008-1073167. - DOI - PubMed

Publication types

Substances

Supplementary concepts